{"id":394319,"date":"2026-03-20T03:28:07","date_gmt":"2026-03-20T03:28:07","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/394319\/"},"modified":"2026-03-20T03:28:07","modified_gmt":"2026-03-20T03:28:07","slug":"check-for-black-particles-childrens-ibuprofen-recalled-local-news","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/394319\/","title":{"rendered":"Check for black particles: Children&#8217;s ibuprofen recalled | Local News"},"content":{"rendered":"<p>Strides Pharma Inc. has initiated a voluntary nationwide <a target=\"_blank\" href=\"https:\/\/www.accessdata.fda.gov\/scripts\/ires\/index.cfm?Product=218947\" rel=\"nofollow noopener\"><strong>recall<\/strong><\/a> of more than 89,000 bottles of children\u2019s liquid ibuprofen after receiving complaints of a gel-like mass and black particles in the medication.<\/p>\n<p>The recall, which began on March 2, affects Children&#8217;s Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bottle.<\/p>\n<p>The product was manufactured in India for Taro Pharmaceuticals U.S.A.<\/p>\n<p><strong>Consumers can identify affected bottles using the following details:<\/strong><\/p>\n<ul>\n<li>\n<p>Product: Children&#8217;s Ibuprofen Oral Suspension, USP<\/p>\n<\/li>\n<li>\n<p>Strength: 100 mg per 5 mL<\/p>\n<\/li>\n<li>\n<p>Size: 4 FL OZ (120 mL)<\/p>\n<\/li>\n<li>\n<p>Lot numbers: 7261973A, 7261974A<\/p>\n<\/li>\n<li>\n<p>Expiration date: Jan. 31, 2027<\/p>\n<\/li>\n<\/ul>\n<p>The U.S. Food and Drug Administration classified the recall as Class II, meaning that use of the product may cause temporary or medically reversible adverse health effects with a low risk of serious consequences.<\/p>\n<p>This product has a recall number of D-0390-2026.<\/p>\n<p>It affects 89,592 bottles.<\/p>\n","protected":false},"excerpt":{"rendered":"Strides Pharma Inc. has initiated a voluntary nationwide recall of more than 89,000 bottles of children\u2019s liquid ibuprofen&hellip;\n","protected":false},"author":2,"featured_media":394320,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[274],"tags":[179715,34525,718,18,135,475,11588,7484,19740,19,17,94994,462,41688,96,68072,5536,33059,179716],"class_list":["post-394319","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-chemicals-in-medicine","tag-clinical-medicine","tag-drugs","tag-eire","tag-health","tag-health-care","tag-health-care-industry","tag-health-sciences","tag-ibuprofen","tag-ie","tag-ireland","tag-medical-treatments","tag-medication","tag-medicinal-chemistry","tag-medicine","tag-pharmaceutical-sciences","tag-pharmacology","tag-pharmacy","tag-products-of-chemical-industry"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ie\/116259383180459409","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/394319","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=394319"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/394319\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/394320"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=394319"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=394319"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=394319"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}